Gamida Cell Stock Total Debt
Gamida Cell fundamentals help investors to digest information that contributes to Gamida Cell's financial success or failures. It also enables traders to predict the movement of Gamida Stock. The fundamental analysis module provides a way to measure Gamida Cell's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Gamida Cell stock.
Gamida |
Gamida Cell Company Total Debt Analysis
Gamida Cell's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Gamida Cell Total Debt | 82.94 M |
Most of Gamida Cell's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Gamida Cell is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
CompetitionBased on the latest financial disclosure, Gamida Cell has a Total Debt of 82.94 M. This is 96.99% lower than that of the Biotechnology sector and 74.46% lower than that of the Health Care industry. The total debt for all United States stocks is 98.44% higher than that of the company.
Gamida Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Gamida Cell's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Gamida Cell could also be used in its relative valuation, which is a method of valuing Gamida Cell by comparing valuation metrics of similar companies.Gamida Cell is currently under evaluation in total debt category among its peers.
Gamida Fundamentals
Return On Equity | -11.04 | |||
Return On Asset | -0.41 | |||
Operating Margin | (26.80) % | |||
Current Valuation | 70.28 M | |||
Shares Outstanding | 132.64 M | |||
Shares Owned By Insiders | 11.57 % | |||
Shares Owned By Institutions | 26.48 % | |||
Number Of Shares Shorted | 10.96 M | |||
Price To Earning | (3.97) X | |||
Price To Book | 117.40 X | |||
Price To Sales | 6.44 X | |||
Revenue | 1.78 M | |||
EBITDA | (70.62 M) | |||
Net Income | (63 M) | |||
Cash And Equivalents | 55.06 M | |||
Cash Per Share | 0.92 X | |||
Total Debt | 82.94 M | |||
Current Ratio | 2.57 X | |||
Book Value Per Share | 0 X | |||
Cash Flow From Operations | (79.12 M) | |||
Short Ratio | 3.51 X | |||
Earnings Per Share | (0.82) X | |||
Target Price | 4.0 | |||
Number Of Employees | 143 | |||
Beta | 1.03 | |||
Market Capitalization | 4.34 M | |||
Total Asset | 102.19 M | |||
Retained Earnings | (479.83 M) | |||
Working Capital | 29.34 M | |||
Current Asset | 56.03 M | |||
Current Liabilities | 9.55 M | |||
Net Asset | 102.19 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Gamida Stock
If you are still planning to invest in Gamida Cell check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gamida Cell's history and understand the potential risks before investing.
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Directory Find actively traded commodities issued by global exchanges |